Myeloproliferatieve neoplasieën (MPN)
TRANSFORM-1: A randomized, double-blind, placebo-controlled, phase 3 study of navitoclax in combination with ruxolitinib versus ruxolitinib in subjects with myelofibrosis
Multipel myeloom
ICON study: A phase 2 study of CC220 (iberdomide) combined with low-dose cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma (IberCd)
Supportive care
DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial
ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation
Stolling
TAP-100: Validation TAP-100 blood collection device
HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study
OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease
Hemoglobinopathie
SCORE: Sickle cell outcome research
Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy
Ga terug naar de algemene homepage Studieprotocollen.